"Obtaining funding for the programme of clinical studies and related manufacturing and good manufacturing practice (GMP) approvals we??ve got to undertake in the West is central to potential licensees extracting value from Inavir. There??s interest in the product, but the level of interest is dependent on whether or not there??s agency funding for the Western trials."
Xfire,
PC just said the level of the interest was dependent on the funding. Isn't that normal? Of course if the funding is granted, the level of interst will be higher than if no funding. It depends on what confince the reader has in Lani.
- Forums
- ASX - By Stock
- good news
"Obtaining funding for the programme of clinical studies and...
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)